Retraction
Notoginsenoside R1 alleviates TNF-α-induced pancreatic β-cell Min6 apoptosis and dysfunction through up-regulation of miR-29a
Paper Information
Record ID:
24446
Author(s):
Publication Date:
June 11, 2019
Retraction Date:
October 21, 2020
(5.1 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Taylor and Francis
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1080/21691401.2020.1807759Citations (11)
11
Total Citations9
Post-Retraction(81.8%)
2
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
3
Within 1 year
4
After 2+ years
1665
Days since retraction (latest)
Ginsenoside in the treatment of type 2 diabetes and its complications: a promising traditional chinese medicine
Yingying Liu, Yang Ju, Yanjun Wang et al. (7 authors)
Frontiers in Pharmacology
Open Access
Published: May 2025
1665 days after retraction
ISG15 increases the apoptosis of β cells in type 1 diabetes
Jie Liu, Maoxia He, Gaopeng Guan et al. (5 authors)
Cellular Signalling
Published: Jan 2025
1 citation
1 citation
1537 days after retraction
Notoginsenoside R1 Protects against Diabetic Nephropathy through TXNIP-NLRP3 Signaling Pathway
Chun‐Ting Zhang, Renyikun Yuan, Siyuan Li et al. (14 authors)
Clinical Complementary Medicine and Pharmacology
Open Access
Published: Jun 2023
2 citations
2 citations
963 days after retraction
Signaling pathways and intervention for therapy of type 2 diabetes mellitus
Rong Cao, Huimin Tian, Yu Zhang et al. (8 authors)
MedComm
Open Access
Published: Jun 2023
31 citations
31 citations
953 days after retraction
Incorporation of NGR1 promotes bone regeneration of injectable HA/nHAp hydrogels by anti-inflammation regulation via a MAPK/ERK signaling pathway
Yi Liu, Yifan Zhang, Zexiang Zheng et al. (8 authors)
Frontiers in Bioengineering and Biotechnology
Open Access
Published: Sep 2022
12 citations
12 citations
702 days after retraction
Molecular study of the proliferation process of beta cells derived from pluripotent stem cells
Saeedeh Akhavan, Sara Tutunchi, Ali Malmir et al. (6 authors)
Molecular Biology Reports
Published: Nov 2021
11 citations
11 citations
378 days after retraction
The Protective Effect of Notoginsenoside R1 on Isoflurane-Induced Neurological Impairment in the Rats via Regulating miR-29a Expression and Neuroinflammation
Meijing Wang, Hongyan Liu, Lufeng Xu et al. (5 authors)
NeuroImmunoModulation
Published: Aug 2021
6 citations
6 citations
307 days after retraction
Phytochemicals: Targeting Mitophagy to Treat Metabolic Disorders
Zuqing Su, Yanru Guo, Xiufang Huang et al. (7 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Aug 2021
24 citations
24 citations
286 days after retraction
TUG1 promotes the expression of IFITM3 in hepatocellular carcinoma by competitively binding to miR-29a
Weiwei Liu, Qian Feng, Wenjun Liao et al. (5 authors)
Journal of Cancer
Open Access
Published: Jan 2021
9 citations
9 citations
72 days after retraction
A review of saponin intervention in metabolic syndrome suggests further study on intestinal microbiota
Zichen Luo, Weichen Xu, Ying Zhang et al. (5 authors)
Pharmacological Research
Published: Jul 2020
81 citations
81 citations
97 days before retraction
<p>Focus on Notoginsenoside R1 in Metabolism and Prevention Against Human Diseases</p>
Hai Liu, Jianqiong Yang, Wanqing Yang et al. (8 authors)
Drug Design Development and Therapy
Open Access
Published: Feb 2020
67 citations
67 citations
263 days before retraction
Quick Stats
Total Citations:
11
Years Since Retraction:
5.1 years
Open Access:
Yes
Last Checked:
Jul 24, 2025